Catalyst Wire Dossier Catalyst Wire Dossier

Bivalent GI.1/GII.4 Norovirus Vaccine

Bivalent GI.1/GII.4 Norovirus vaccine · Vaxart
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Bivalent GI.1/GII.4 Norovirus Vaccine, covering 2025-04-15 to 2025-04-15. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Determine the Safety and Immunogenicity of Bivalent GI.1 and GII.4 Vaccines in Healthy Volunteers [Phase 2]

See pricing